336 related articles for article (PubMed ID: 11110418)
1. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
2. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
3. [The biosafety of the HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
Adachi N; Könü DL; Frei K; Yonekawa Y
No Shinkei Geka; 2000 Nov; 28(11):965-74. PubMed ID: 11127592
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
5. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
[TBL] [Abstract][Full Text] [Related]
7. Local inflammation and devascularization--in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma.
Floeth FW; Shand N; Bojar H; Prisack HB; Felsberg J; Neuen-Jacob E; Aulich A; Burger KJ; Bock WJ; Weber F
Cancer Gene Ther; 2001 Nov; 8(11):843-51. PubMed ID: 11773974
[TBL] [Abstract][Full Text] [Related]
8. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
Kruse CA; Lamb C; Hogan S; Smiley WR; Kleinschmidt-Demasters BK; Burrows FJ
Cancer Gene Ther; 2000 Jan; 7(1):118-27. PubMed ID: 10678364
[TBL] [Abstract][Full Text] [Related]
9. [The HSV-TK/GCV gene therapy in five cases of recurrent glioblastoma multiforme].
Adachi N; Könü DL; Frei K; Yonekawa Y
No Shinkei Geka; 2000 Oct; 28(10):865-71. PubMed ID: 11070906
[TBL] [Abstract][Full Text] [Related]
10. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
11. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells.
Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054
[TBL] [Abstract][Full Text] [Related]
12. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
[TBL] [Abstract][Full Text] [Related]
13. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
Zhao Y; Zhang X; Hui H
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):113-5. PubMed ID: 10488424
[TBL] [Abstract][Full Text] [Related]
14. Combined HSV-TK/IL-2 gene therapy in patients with recurrent glioblastoma multiforme: biological and clinical results.
Colombo F; Barzon L; Franchin E; Pacenti M; Pinna V; Danieli D; Zanusso M; Palù G
Cancer Gene Ther; 2005 Oct; 12(10):835-48. PubMed ID: 15891772
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
16. Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene.
Carrió M; Romagosa A; Mercadé E; Mazo A; Nadal M; Gómez-Foix AM; Fillat C
Gene Ther; 1999 Apr; 6(4):547-53. PubMed ID: 10476214
[TBL] [Abstract][Full Text] [Related]
17. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
[TBL] [Abstract][Full Text] [Related]
18. Combination suicide/cytokine gene therapy as adjuvants to a defective herpes simplex virus-based cancer vaccine.
Toda M; Martuza RL; Rabkin SD
Gene Ther; 2001 Feb; 8(4):332-9. PubMed ID: 11313808
[TBL] [Abstract][Full Text] [Related]
19. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
[TBL] [Abstract][Full Text] [Related]
20. Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy.
Izquierdo M; Martín V; de Felipe P; Izquierdo JM; Pérez-Higueras A; Cortés ML; Paz JF; Isla A; Blázquez MG
Gene Ther; 1996 Jun; 3(6):491-5. PubMed ID: 8789798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
